Abstract
Interleukin 15 (IL-15) is a novel cytokine that has recently been cloned and expressed. Whereas it has no sequence homology with IL-2, IL-15 interacts with components of the IL-2 receptor (IL-2R). In the present study we performed a functional analysis of recombinant IL-15 on phenotypically and functionally distinct populations of highly purified human natural killer (NK) cells. The CD56bright subset of human NK cells constitutively expresses the high affinity IL-2R and exhibits a brisk proliferative response after the binding of picomolar amounts of IL-2. Using a proliferation assay, IL-15 demonstrated a very steep dose-response curve that was distinct from the dose-response curve for IL-2. The proliferative effects of IL-15 could be abrogated by anti-IL-2R beta (p75), but not by anti-IL-2R alpha (p55). The proliferative effects of IL-2 on CD56bright NK cells could be inhibited by both antibodies. CD56dim NK cells express the intermediate affinity IL-2R in the absence of the high affinity IL-2R. Activation of CD56dim NK cells by IL-15 was similar to that of IL-2 as measured by enhanced NK cytotoxic activity, antibody-dependent cellular cytotoxicity, and NK cell production of interferon gamma, tumor necrosis factor alpha, and granulocyte/macrophage colony-stimulating factor. The IL-15-enhanced NK cytotoxic activity could be completely blocked by anti-IL-2R beta monoclonal antibody. The binding of radiolabeled IL-2 and IL-15 to CD56dim NK cells was inhibited in the presence of anti-IL-2R beta. Scatchard analysis of radiolabeled IL-15 and IL-2 binding to NK-enriched human lymphocytes revealed the presence of high and intermediate affinity receptors for both ligands. IL-15 is a ligand that activates human NK cells through components of the IL-2R in a pattern that is similar but not identical to that of IL-2. Unlike IL-2, IL-15 is produced by activated monocytes/macrophages. The discovery of IL-15 may increase our understanding of how monocytes/macrophages participate in the regulation of NK cell function.
MeSH Terms
Antigens, CD/analysis
Antigens, Differentiation, T-Lymphocyte/analysis
CD56 Antigen
Cell Line
Cytokines/biosynthesis
Cytotoxicity, Immunologic/drug effects
Humans
Interleukin-15
Interleukin-2/metabolism
Interleukins/metabolism,pharmacology
Killer Cells, Natural/drug effects,immunology,metabolism
Lymphocyte Activation/drug effects
Receptors, Interleukin-2/physiology
Chemicals
Antigens, CD
Antigens, Differentiation, T-Lymphocyte
CD56 Antigen
Cytokines
Interleukin-15
Interleukin-2
Interleukins
Receptors, Interleukin-2
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Carson W E
Department of Medicine, Roswell Park Cancer Institute, Buffalo, New York 14263.
Giri J G
Lindemann M J
Linett M L
Ahdieh M
Paxton R
Anderson D
Eisenmann J
Grabstein K
Caligiuri M A
References (24)
24 references, click to expand
-
Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist.
Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3725-9
PMID: 8097322
-
The IL-2/IL-2 receptor system: a current overview.
Cell. 1993 Apr 9;73(1):5-8
PMID: 8462103
-
Expression of a functional c-kit receptor on a subset of natural killer cells.
J Exp Med. 1993 Sep 1;178(3):1079-84
PMID: 7688785
-
Hematopoietic regulators: redundancy or subtlety?
Blood. 1993 Dec 15;82(12):3515-23
PMID: 8260692
-
Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor.
Science. 1994 May 13;264(5161):965-8
PMID: 8178155
-
Expression and ligand binding characterization of the beta-subunit (p75) ectodomain of the interleukin-2 receptor.
Biochemistry. 1994 May 17;33(19):5838-45
PMID: 8180212
-
Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15.
EMBO J. 1994 Jun 15;13(12):2822-30
PMID: 8026467
-
Toxoplasma gondii induces a T-independent IFN-gamma response in natural killer cells that requires both adherent accessory cells and tumor necrosis factor-alpha.
J Immunol. 1993 May 1;150(9):3982-9
PMID: 8473745
-
A monoclonal antibody that appears to recognize the receptor for human T-cell growth factor; partial characterization of the receptor.
Nature. 1982 Nov 18;300(5889):267-9
PMID: 6815536
-
The interaction of monoclonal antibodies with MHC class I antigens on mouse spleen cells. I. Analysis of the mechanism of binding.
J Immunol. 1984 Feb;132(2):751-8
PMID: 6690617
-
The interleukin 2 receptor. Functional consequences of its bimolecular structure.
J Exp Med. 1987 Oct 1;166(4):1055-69
PMID: 3116143
-
Interleukin-2: inception, impact, and implications.
Science. 1988 May 27;240(4856):1169-76
PMID: 3131876
-
Activation of natural killer cells via the p75 interleukin 2 receptor.
J Exp Med. 1989 Jul 1;170(1):291-6
PMID: 2787381
-
Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes.
J Exp Med. 1989 Sep 1;170(3):827-45
PMID: 2504877
-
Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptors.
J Exp Med. 1990 May 1;171(5):1509-26
PMID: 1692080
-
Constitutive expression of high affinity interleukin 2 receptors on human CD16-natural killer cells in vivo.
J Exp Med. 1990 May 1;171(5):1527-33
PMID: 2139697
-
Human natural killer cell adhesion molecules. Differential expression after activation and participation in cytolysis.
J Immunol. 1990 Nov 15;145(10):3194-201
PMID: 1700001
-
Biology and clinical relevance of human natural killer cells.
Blood. 1990 Dec 15;76(12):2421-38
PMID: 2265240
-
Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF.
J Exp Med. 1992 Mar 1;175(3):779-88
PMID: 1346796
-
Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients.
J Exp Med. 1992 Mar 1;175(3):789-96
PMID: 1346797
-
Characterization of the interleukin 2 receptors (IL-2R) expressed on human natural killer cells activated in vivo by IL-2: association of the p64 IL-2R gamma chain with the IL-2R beta chain in functional intermediate-affinity IL-2R.
J Exp Med. 1992 Aug 1;176(2):531-41
PMID: 1500859
-
Selective modulation of human natural killer cells in vivo after prolonged infusion of low dose recombinant interleukin 2.
J Clin Invest. 1993 Jan;91(1):123-32
PMID: 7678599
-
Identification of a direct interaction between interleukin 2 and the p64 interleukin 2 receptor gamma chain.
Proc Natl Acad Sci U S A. 1993 Mar 15;90(6):2428-32
PMID: 7681595
-
Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts.
Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):6115-9
PMID: 8100999